Exploring how nature and anti-racist practices can improve health for young BIPOC individuals.
Examining Anti-Racist Healing in Nature to Protect Telomeres of Transitional Age BIPOC for Health Equity.
This study is looking at how experiences of discrimination impact the health of young people of color, ages 18 to 26, and whether being aware of social inequalities can help them cope with stress from racism and improve their health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | San Francisco State University NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11100878 on NIH RePORTER |
What this research studies
This research investigates how experiences of discrimination affect the health of Black, Indigenous, and People of Color (BIPOC) aged 18-26, particularly focusing on cellular aging as measured by telomere length. The study aims to understand the role of critical consciousness—awareness of social inequalities—in coping with racism-related stress and its potential to mitigate health disparities. Participants will engage in biobehavioral research methods that explore the connections between discrimination, critical consciousness, and health outcomes. The findings could inform interventions aimed at reducing chronic health issues in BIPOC communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are BIPOC individuals aged 18-26 who have experienced discrimination.
Not a fit: Patients outside the age range of 18-26 or those who do not identify as BIPOC may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to strategies that improve health outcomes and reduce chronic disease risks for young BIPOC individuals.
How similar studies have performed: Previous research has shown that addressing social determinants of health can lead to improved health outcomes, suggesting that this approach may also be effective.
Where this research is happening
San Francisco, United States
- San Francisco State University — San Francisco, United States (Active)
Researchers
- Principal investigator: Marquez-Magana, Leticia Maria — San Francisco State University
- Study coordinator: Marquez-Magana, Leticia Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.